Clinical Trials Logo

Clinical Trial Details — Status: Active, not recruiting

Administrative data

NCT number NCT05551377
Other study ID # NL.80610.091.22
Secondary ID MJFF-020200
Status Active, not recruiting
Phase N/A
First received
Last updated
Start date January 18, 2023
Est. completion date June 2024

Study information

Verified date November 2023
Source Radboud University Medical Center
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Autonomic dysfunction is common and often underrecognized in Parkinson's disease (PD). Orthostatic hypotension (OH) affects up to a third of PD patients and often coincides with supine hypertension. This co-occurrence complicates pharmacological treatment as treatment of one can negatively affect the other. Head-up tilt sleeping (HUTS) could improve both. This phase II randomized controlled trial (RCT) aims to investigate the efficacy and tolerability of this understudied intervention, leading to optimal implementation strategies.


Description:

Autonomic dysfunction is common and often underrecognized in Parkinson's disease (PD). Orthostatic hypotension (OH) affects up to a third of PD patients and about half of them also exhibit supine hypertension. In current clinical practice both are undertreated. The common co-occurrence of OH and supine hypertension complicates pharmacological treatment as improvement of one can be accomplished only at the expense of the other. Head-up tilt sleeping (HUTS) is the only intervention known that could improve both. The concept of HUTS is based on several small-scale observational studies and expert opinion. Although HUTS has been proposed as an effective and even first choice non-pharmacological treatment for OH for over three decades, it is often not advised to patients because of lack of evidence on its effectiveness and on how to implement it. The Heads-Up trial is a multicenter home-based double-blind phase II RCT. The study aims to investigate the efficacy and tolerability of HUTS, leading to optimal implementation strategies of HUTS to treat orthostatic hypotension and supine hypertension.


Recruitment information / eligibility

Status Active, not recruiting
Enrollment 50
Est. completion date June 2024
Est. primary completion date June 2024
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: - Orthostatic hypotension defined as a systolic BP decrease of =20 mmHg, or a diastolic decrease of =10 mmHg, within 3 min after changing from a supine to standing position OR mean standing BP of =75 mmHg (marker for symptomatic orthostatic hypotension). In patients with supine hypertension, a decrease in systolic BP of = 30 mmHg is required; - Orthostatic intolerance: direct complaints (dizziness, blurry vision, etc.) and/or indirect signs (falls or freezing episodes that relate to postural challenge); - Supine hypertension defined as a systolic BP of =140 mmHg, and/or diastolic of =90 mmHg, after 5 min of supine rest; - Idiopathic PD or parkinsonism (multiple system atrophy, progressive supranuclear palsy, corticobasal degeneration, vascular parkinsonism and Lewy body dementia); - Ability to walk (with or without a walking aid), as subjectively determined by the researcher; - Stable medication regimens for orthostatic hypotension and supine hypertension during the trial; Exclusion Criteria: - Inability to follow instructions and complete questionnaires, as assessed by the researcher;

Study Design


Intervention

Other:
Head-up tilt sleeping
Whole-body head-up tilt sleeping (HUTS) will be carried out in three different angles, each for the duration of two weeks. Prior to the first angle the participant will sleep in a horizontal position for 1 week. The different angles will be installed using a wedge between the mattress and bed frame.

Locations

Country Name City State
Netherlands Leiden University Medical Center Leiden Zuid Holland
Netherlands Radboudumc Nijmegen Gelderland

Sponsors (3)

Lead Sponsor Collaborator
Radboud University Medical Center Leiden University Medical Center, Michael J. Fox Foundation for Parkinson's Research

Country where clinical trial is conducted

Netherlands, 

Outcome

Type Measure Description Time frame Safety issue
Other Timed up and go test (TUG) Measurement of the time that the participant takes to rise from a chair, walk three meters, turn around 180 degrees, walk back to the chair, and sit down while turning 180 degrees Pre-intervention (day before week 1, T0) and post-intervention (day after week 7,T1)
Other Symptoms of Parkinson's disease Movement disorders society unified disease rating scale (MDS-UPDRS). Scores range from 0 to 199, with a higher score indicating a more severe impairment related to Parkinson's disease. Pre-intervention (day before week 1, T0) and post-intervention (day after week 7,T1)
Other Quality of sleep Pittsburgh Sleep Quality Index (PSQI). Score ranges from 0 to 21, with 21 indicating a worse sleep quality. Pre-intervention (day before week 1, T0) and post-intervention (day after week 7,T1)
Other Fear of falling Falls Efficacy Scale (FES). Scores ranges from 16 to 67, with a higher score meaning a worse fear of falling. Pre-intervention (day before week 1, T0) and post-intervention (day after week 7,T1)
Other Subjective level of physical activity Longitudinal Aging Study Amsterdam (LASA) Physical Activity Questionnaire (LAPAQ). Score corresponds to time spend doing physical activities. A higher score indicates a more active last two weeks. Pre-intervention (day before week 1, T0) and post-intervention (day after week 7,T1)
Other Cardiovascular autonomic symptoms Selected cardiovascular questions from the Scales for Outcomes in Parkinson's Disease - Autonomic Dysfunction (SCOPA-AUT). Scored 0 to 9, a worse score means more symptoms of orthostatic hypotension. Pre-intervention (day before week 1, T0) and post-intervention (day after week 7,T1)
Other Experienced quality of life Quality of life questionnaire: the Parkinson's disease questionnaire (PDQ-39). Scores range from 0 to 100, with a higher score indicating a worse quality of life. Pre-intervention (day before week 1, T0) and post-intervention (day after week 7,T1)
Other Experienced anxiety and depression Quality of life questionnaire: the hospital anxiety and depression scale (HADS). Scores range from 0 to 21 for depression and anxiety, a score between 0-7 means no anxiety or depression, 8-14 possibility of an anxiety or depressive disorder and 15-21 likely a depressive or anxiety disorder. Pre-intervention (day before week 1, T0) and post-intervention (day after week 7,T1)
Other Mental health Quality of life questionnaire: the Mental Health Continuum-Short Form (MHC-SF). Scores range from 0 to 70, with a higher score meaning a better emotional wellbeing. Pre-intervention (day before week 1, T0) and post-intervention (day after week 7,T1)
Primary Average overnight supine blood pressure Average overnight supine blood pressure (mmHg) from the 24h ambulatory blood pressure measurement (ABPM) Measured four times: in week 1, 3, 5 and 7
Secondary Daily supine blood pressure Supine blood pressure (mmHg) measured every morning directly after awakening before getting out of bed Daily in week 1 up to and including week 7
Secondary Orthostatic blood pressure Standing orthostatic blood pressure test (mmHg). Measured in clinic and home-based guided by a researcher via video call. Measured six times: in-clinic (T0; pre-intervention), in week 1, 3, 5 and 7, and in-clinic on the day after week 7 ends (T1; post-intervention)
Secondary 24h ABPM parameters 24h ABPM parameters blood pressure variability (mmHg), nocturnal blood pressure dipping (mmHg) and average daytime blood pressure (mmHg). Each of these measures will be derived from the 24 hour blood pressure measurements, and reported separately. In week 1, 3, 5 and 7
Secondary Orthostatic tolerance Self-reported burden of symptoms of orthostatic hypotension (Orthostatic hypotension questionnaire (OHQ)). The score ranges from 0 to 100, with a higher number meaning worse symptoms of orthostatic hypotension. Week 1, 3, 5 and 7
Secondary Nocturia Self-reported frequency of daytime and night time urination and impact on quality of life (International Consultation on Incontinence Questionnaire Nocturia Module (ICIQ-N)) Week 1, 3, 5 and 7
Secondary Subjective comfort of HUTS (head up tilted sleeping) Self-reported tolerability of the head up tilted sleeping at different angles including questions about sleep duration, sleep quality and comfort, and feeling rested in the morning. Week 1, 3, 5 and 7
Secondary Falls Self-reported falls and in case of a fall additional questions about the time and circumstances Week 1, 3, 5 and 7
Secondary Overnight change in body weight Weight (kg) difference between the evening and the morning, both measured after micturition Daily in week 1 up to and including week 7
Secondary Nighttime urine production Urine volume measured in a urinal (ml) Week 1, 3, 5 and 7
Secondary Barriers and facilitators of the intervention Structured interview Immediately post-intervention (day after week 7, T1)
See also
  Status Clinical Trial Phase
Completed NCT05415774 - Combined Deep Brain Stimulation in Parkinson's Disease N/A
Recruiting NCT04691661 - Safety, Tolerability, Pharmacokinetics and Efficacy Study of Radotinib in Parkinson's Disease Phase 2
Active, not recruiting NCT05754086 - A Multidimensional Study on Articulation Deficits in Parkinsons Disease
Completed NCT04045925 - Feasibility Study of the Taïso Practice in Parkinson's Disease N/A
Recruiting NCT04194762 - PARK-FIT. Treadmill vs Cycling in Parkinson´s Disease. Definition of the Most Effective Model in Gait Reeducation N/A
Completed NCT02705755 - TD-9855 Phase 2 in Neurogenic Orthostatic Hypotension (nOH) Phase 2
Terminated NCT03052712 - Validation and Standardization of a Battery Evaluation of the Socio-emotional Functions in Various Neurological Pathologies N/A
Recruiting NCT05830253 - Free-living Monitoring of Parkinson's Disease Using Smart Objects
Recruiting NCT03272230 - Assessment of Apathy in a Real-life Situation, With a Video and Sensors-based System N/A
Recruiting NCT06139965 - Validity and Reliability of the Turkish Version of the Comprehensive Coordination Scale in Parkinson's Patients
Completed NCT04580849 - Telerehabilitation Using a Dance Intervention in People With Parkinson's Disease N/A
Completed NCT03980418 - Evaluation of a Semiconductor Camera for the DaTSCAN™ Exam N/A
Completed NCT04477161 - Effect of Ketone Esters in Parkinson's Disease N/A
Completed NCT04942392 - Digital Dance for People With Parkinson's Disease During the COVID-19 Pandemic N/A
Terminated NCT03446833 - LFP Beta aDBS Feasibility Study N/A
Completed NCT03497884 - Individualized Precise Localization of rTMS on Primary Motor Area N/A
Completed NCT05538455 - Investigating ProCare4Life Impact on Quality of Life of Elderly Subjects With Neurodegenerative Diseases N/A
Recruiting NCT04997642 - Parkinson's Disease and Movement Disorders Clinical Database
Completed NCT04117737 - A Pilot Study of Virtual Reality and Antigravity Treadmill for Gait Improvement in Parkinson N/A
Recruiting NCT03618901 - Rock Steady Boxing vs. Sensory Attention Focused Exercise N/A